Evidence map›Paper›PMID 32231249›Full record

ArticleBone marrow transplantation2020

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation.

Sarah Whiteside, Alex Chin, Gaurav Tripathi, Poonam Dharmani-Khan, Marketa Markova, Petra Keslova, Petr Sedlacek, Michelle N Geddes, Victor Lewis, Monica Modi and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Sarah WhitesideUniversity of Calgary, Calgary, AB, Canada. sarah.whiteside1@ucalgary.ca.ORCID http://orcid.org/0000-0003-4654-2510
Alex ChinUniversity of Calgary, Calgary, AB, Canada.
Gaurav TripathiUniversity of Calgary, Calgary, AB, Canada.
Poonam Dharmani-KhanUniversity of Calgary, Calgary, AB, Canada.
Marketa MarkovaInstitute of Hematology and Blood Transfusion, Prague, Czech Republic.
Petra Keslova2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Petr Sedlacek2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Michelle N GeddesUniversity of Calgary, Calgary, AB, Canada.
Victor LewisUniversity of Calgary, Calgary, AB, Canada.
Monica ModiUniversity of Calgary, Calgary, AB, Canada.
Amit KalraUniversity of Calgary, Calgary, AB, Canada.
Rosy DabasUniversity of Calgary, Calgary, AB, Canada.
Ariz AkhterUniversity of Calgary, Calgary, AB, Canada.
Loree LarrattAlberta Health Services, Calgary and Edmonton, AB, Canada.
Tiffany van SlykeAlberta Health Services, Calgary and Edmonton, AB, Canada.
Joseph BrandweinAlberta Health Services, Calgary and Edmonton, AB, Canada.
Stephen R SpellmanImmunobiology Research, Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Richard LeighUniversity of Calgary, Calgary, AB, Canada.
Andrew DalyUniversity of Calgary, Calgary, AB, Canada.
Faisal M KhanUniversity of Calgary, Calgary, AB, Canada.
Jan StorekUniversity of Calgary, Calgary, AB, Canada.
Alberta Health Services · CAUniversity of Calgary · CACharles University · CZInstitute of Haematology and Blood Transfusion · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopy is excessive production of IgE in response to allergens. We evaluated in patients undergoing allogeneic hematopoietic cell transplantation (HCT) the following hypotheses: (1) Atopy is "curable" in atopic patients receiving HCT from a nonatopic donor (D-R+), and (2) Atopy is transferable from atopic donors to nonatopic recipients (D+R-). Atopic patients with atopic donors (D+R+) and non-atopic patients with non-atopic donors (D-R-) served as controls. We measured levels of multiallergen-specific IgE (A-IgE, atopy defined as ≥0.35 kU

Indexed as

Hematopoietic Stem Cell TransplantationHypersensitivity, ImmediateAllergensHumansImmunoglobulin EAllergensImmunoglobulin E

Identifiers

PMID32231249
OpenAlexW3014054298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.